Iconiq Capital, LLC Argenx Se Transaction History
Iconiq Capital, LLC
- $4.79 Billion
- Q4 2024
A detailed history of Iconiq Capital, LLC transactions in Argenx Se stock. As of the latest transaction made, Iconiq Capital, LLC holds 370 shares of ARGX stock, worth $219,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
370Holding current value
$219,583% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
434Shares Held
28.8MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.27 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.82 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.37 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.06 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$735 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...